Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-03-04 @ 11:59 AM
Study NCT ID:
NCT04501666
Status:
COMPLETED
Last Update Posted:
2024-07-10
First Post:
2020-07-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Sponsor:
Galderma R&D
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RD.06.SPR.202685
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None